Our people
    make it happen.

Look beyond experience.

Everyone talks about how experienced and educated their people are.

Experience and education do matter — and we have that in spades — but that just gets you in the door.

Paul Ambrose Paul G. Ambrose, Pharm.D., FIDSA President Learn More
Sujata Bhavnani Sujata M. Bhavnani, Pharm.D., M.S. Executive VP Learn More
Christopher Rubino Christopher M. Rubino, Pharm.D. Executive VP Learn More

Mindset matters.

To truly excel, you need a team that shares the same mindset.

And what is our unique mindset?

It’s the unwavering conviction that PK-PD should be a platform for drug-development, shaping the way antimicrobials are used to care for patients.

Add to this a penchant for unconventional thinking along with a stubborness to succeed and you have a blueprint for achieving something greater than the proverbial sum of the parts.

It was this blueprint that was critical in bringing challenging antibiotics to market, succeeding where others had failed.

The Story of Oritavancin

This is what sets our team apart, and why drug developers and regulators have sought us out over our entire history.

Bottom line: We lower your risk.